查詢結果分析
相關文獻
- Serum Sodium Predicts Prognosis in Liver Transplant Patients
- Pulmonary Function Changes in Cirrhotic Patients
- Recent Advances in Hepatopulmonary Syndrome
- 非酒精性肝硬化患者接受活體肝臟移植術後於加護病房發生瞻妄之危險因子
- Hepatopulmonary Syndrome與肝臟移植--術前之評估處置
- Model for End-stage Liver Disease and Organ Allocation in Liver Transplantation: Where are We and Where Shoud We Go?
- 肝腎症候群
- 肝腎症候群
- 照護一位酒精性肝硬化行肝臟移植術後病人之加護經驗
- 肝硬化病人低血鈉
頁籤選單縮合
題名 | Serum Sodium Predicts Prognosis in Liver Transplant Patients=血鈉濃度預測肝臟移植病患之預後 |
---|---|
作者 | 呂宜樺; 李威震; 王忠信; 鄭昌錡; 田亞中; 張明揚; 林展宇; 陳永昌; 方基存; 楊智偉; Lu, Yi-hua; Lee, Wei-chen; Wong, Chung-shun; Jenq, Chang-chyi; Tian, Ya-chung; Chang, Ming-yang; Lin, Chan-yu; Chen, Yung-chang; Fang, Ji-tseng; Yang, Chih-wei; |
期刊 | 臺灣腎臟醫學會雜誌 |
出版日期 | 20090900 |
卷期 | 23:3 2009.09[民98.09] |
頁次 | 頁164-170+188 |
分類號 | 416.246 |
語文 | eng |
關鍵詞 | 低血鈉; 肝臟移植; 肝硬化; Hyponatremia; Liver transplant; Cirrhosis; |
英文摘要 | Background: Hyponatremia is common in advanced cirrhosis patients. This condition is associated with reduced survival in patients with end-stage liver disease awaiting liver transplantation. Hyponatremia has been proved as a posttransplantation outcome predictor in cirrhosis patient undergoing liver transplantation. This study assesses the prognostic value of serum sodium level, not only pre-operation but also post-operation, in liver transplant patients. Methods: One hundred forty-nine consecutive cirrhosis patients who had received liver transplants during a 7-year period were enrolled in this study. Demographic data as well as pre- and post-transplant clinical and laboratory variables were retrospectively recorded. Results: The overall 1-year mortality rate was 22.1%. Patients with pre-transplant serum sodium ≤135 mmol/L had significantly higher 1-month, 3-month, and 1-year mortality. In patients with serum sodium ≤135 mmol/L on Day 3 post-liver transplant, 1-year mortality was significantly increased, but 1-month and 3-month mortality were not. As a predictor of 3-month mortality, the discriminatory power of pre-transplant serum sodium concentration was superior to that of concentrations observed on post-transplant Day 1 and Day 3. For predicting 1-year mortality, the pre-transplant and post-transplant Day 3 serum sodium levels displayed better areas under the receiver operating characteristic curves than post-transplant Day 1 serum sodium concentration did. Finally, cumulative survival rates at 1-year follow-up differed significantly (p<0.05) between patients with pre-transplant and post-transplant Day 3 serum sodium>135 mmol/L and those with serum sodium ≤135 mmol/L. Conclusions: Low serum sodium level at pre-transplant and at Day 3 post-transplant is associated with poor short-term prognosis. In cirrhosis patients, low sodium level should be considered a mortality risk factor before transplantation as well as a risk factor for poor early post-transplantation outcome. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。